Gerd Bendas

20PUBLICATIONS
47CO-AUTHORS
Separation technologiesMolecular targetsCharacterisation of biological macromoleculesHaematological tumoursToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 10, 2026
Rapid Two-Step Multicomponent Synthesis and Structure-degradation Relationships of Selective HDAC6 PROTAC Degraders.

|Aug 17, 2026
Novel Class I HDAC Inhibitors Sensitize Ovarian Cancer Cells for Cisplatin and Niraparib via an HDAC3-SLFN11 Axis.

|Apr 17, 2026
Fully Synthetic Non-Carbohydrate Heparin Mimetics-Perspectives for Therapeutic Anticoagulation and Beyond?

|Apr 16, 2026
Comparing Heparin and Heparin Mimetics in Targeting Immunomodulatory Proteins from Platelets to Activate T Cell-Dependent Immune Response in Oncology.

|Oct 06, 2025
Increased efficacy of PARP inhibitors against cisplatin-sensitive and -resistant ovarian cancer cells mediated via ATR and ATM inhibition.

Philipp König, Leon Bade, Julia Maria Eichhorn

|Sep 19, 2025
Target Engagement Studies and Kinetic Live-Cell Degradation Assays Enable the Systematic Characterization of Histone Deacetylase 6 Degraders.

Maria Hanl, Felix Feller, Irina Honin

Pageof 4

Frequent Collaborators

6 joint publications

Finn K Hansen

4 joint publications

Michael Gütschow

3 joint publications

Vito Ferro

3 joint publications

Shiyang Zhai